The acceleration of the Generic Pharmaceuticals Market Growth can be attributed to the aggressive diversification strategies adopted by top-tier pharmaceutical manufacturers. With the traditional small-molecule market reaching a point of saturation, companies are pivoting toward "specialty generics" that target specific therapeutic niches like oncology and central nervous system (CNS)...

The pharmaceutical and biotechnology industries across North America are rapidly adopting advanced informatics solutions to accelerate drug discovery and improve research efficiency. The increasing need to reduce drug development timelines, manage large biological datasets, and enhance precision in clinical research is driving the demand for innovative informatics platforms. The market is...